GFER
MOLECULAR TARGETgrowth factor, augmenter of liver regeneration
GFER (growth factor, augmenter of liver regeneration) is targeted by 31 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GFER
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | pterostilbene | 1.10 | 2 |
| 2 | Resveratrol | 1.10 | 2 |
| 3 | Phenelzine | 1.10 | 2 |
| 4 | piceatannol | 1.10 | 2 |
| 5 | Promazine | 1.10 | 2 |
| 6 | Promethazine | 1.10 | 2 |
| 7 | Arachidonic Acid | 0.69 | 1 |
| 8 | caffeic acid | 0.69 | 1 |
| 9 | Chlorogenic Acid | 0.69 | 1 |
| 10 | Methylene Blue | 0.69 | 1 |
| 11 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 0.69 | 1 |
| 12 | Kaempferols | 0.69 | 1 |
| 13 | Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as | 0.69 | 1 |
| 14 | Rutin | 0.69 | 1 |
| 15 | 2-Methoxyestradiol | 0.69 | 1 |
| 16 | Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as | 0.69 | 1 |
| 17 | Aurintricarboxylic Acid | 0.69 | 1 |
| 18 | Bufexamac | 0.69 | 1 |
| 19 | calycosin | 0.69 | 1 |
| 20 | Disulfiram | 0.69 | 1 |
| 21 | Catechin | 0.69 | 1 |
| 22 | Equilin | 0.69 | 1 |
| 23 | Vanillic Acid | 0.69 | 1 |
| 24 | Masoprocol | 0.69 | 1 |
| 25 | Perphenazine | 0.69 | 1 |
| 26 | propionylpromazine hydrochloride | 0.69 | 1 |
| 27 | 4-Hydroxybenzoate-3-Monooxygenase | 0.69 | 1 |
| 28 | alphitonin [Supplementary Concept] from | 0.69 | 1 |
| 29 | Thioridazine | 0.69 | 1 |
| 30 | triflupromazine hydrochloride | 0.69 | 1 |
| 31 | urolithin b | 0.69 | 1 |
About GFER as a Drug Target
GFER (growth factor, augmenter of liver regeneration) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 31 compounds with documented GFER interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GFER inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.